Guest guest Posted April 15, 2006 Report Posted April 15, 2006 I need some specific help here. Blue Cross/Blue Shield of Georgia has denied coverage of Arimmidex based on the fact that it is only approved for women in the treatment of breast cancer. When they denied the appeal, they said that even though it was clearly an aromatase inhibitor, its use in men was " experimental " . Arimidex is on the BCBS approved formulary drug list, just not for men. So the next step is a panel review where I have the pleasure of presenting my case to a Board. I am gunning for bear. Can you all help me with experience and detail? I would greatly appreciate it. Thanks. Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.